Compare GameStop Corp. (GME) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GameStop Corp. vs Regeneron Pharmaceuticals Inc — how do they compare? GameStop Corp. trades at $18.84 (market cap $8.44B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 9.7× GameStop Corp.'s market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while GameStop Corp. pays none. Which is the better fit depends on your goals.
| GME | REGN | |
|---|---|---|
Market Cap | $8.44B | $82.06B |
Sector | Consumer Cyclical | Health |
52-Week High | $27.69 | $812.27 |
52-Week Low | $18.79 | $555.51 |
Enterprise Value | $4.42B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GameStop Corp.
Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
